OpenEvidence's Rapid Growth in Healthcare AI

Artificial intelligence platform OpenEvidence has secured $200 million in new funding, bringing its valuation to $6 billion, the company announced today. This marks a significant milestone for the healthcare-focused AI startup, which was valued at $3.5 billion just three months prior during its previous funding round.

Image Source Note: The image is AI-generated, and the image licensing service is Midjourney

Revolutionizing Medical Knowledge Access

Founded in 2022, OpenEvidence specializes in providing doctors and nurses with instant access to medical research from leading journals including The Journal of the American Medical Association and The New England Journal of Medicine. The platform's AI models have been trained on vast amounts of peer-reviewed medical literature to help healthcare professionals make faster, more informed decisions.

"Our mission is to put medical knowledge at clinicians' fingertips when they need it most," said a company spokesperson. Currently, verified healthcare professionals can use OpenEvidence's tools free of charge, with the company generating revenue through targeted advertising.

Surging Adoption Rates

The platform has experienced explosive growth since its inception. Monthly clinical consultations on OpenEvidence have nearly doubled since July 2025, reaching 15 million consultations per month. This rapid adoption demonstrates the growing demand for AI-assisted decision support tools among medical professionals.

"The numbers speak volumes about how healthcare providers are embracing this technology," noted an industry analyst. "When you see adoption rates like this in the conservative medical field, you know you're looking at something transformative."

Investor Confidence in Medical AI

The latest funding round was led by Google Ventures, with participation from prominent investors including Sequoia Capital, Kleiner Perkins, Blackstone, Thrive Capital, Coatue Management, Bond, and Craft Ventures. This diverse group of backers reflects strong confidence in OpenEvidence's business model and growth potential.

The fresh capital will be used to:

• Expand the platform's knowledge base
• Develop new features for hospital integration
• Accelerate international expansion efforts
• Grow the engineering and medical teams

Key Points:

🌟 $200 million raised at $6 billion valuation shows investor confidence in medical AI solutions 📈 Monthly consultations reached 15 million, nearly doubling since July 💼 Funding led by Google Ventures with participation from top-tier investors 🏥 Platform provides free access to verified healthcare professionals 📚 Trained on content from leading medical journals